MR-1817

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameMR-1817

Drug Alias NameMR-1817VRA-175

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVanilloid receptor antagonists

TargetsTransient receptor potential cation channel subfamily V member 1

Therapy Area/IndicationsPain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsPain

ATC CodeN/A